Re: Live Chat with Vergel on Wednesday, February 16, 2005, at 9 p.m. EST

[Guest guest]

> Guys> > I am forwarding this email from thebody.com> > I am very excited to be able to do my first "live chat" on salvage therapy and multi drug resistance. I hope to be able to answer any questions on Fuzeon, Tipranavir, TMC 114 and 125, TANOX TNX355 infusion, Reverset, CCR5 inhibitors, double PI boosted combos, etc> > You can send questions to thebody.com now. After the chat, thebody.com will send a transcript for those who cannot attend.> > I am hopeful that this new way to reach people may help many that do not have access to seminars or treatment education in their area. Besides, you can do this while just wearing your underwear!> > Hope to see you in the chat!> > Vergel> www.salvagetherapies.org

In case some of you guys weren't able to view 's forwarded message in the digest version, here are links to and copies of the announcements:

http://www.thebody.com/submit/?/chat/main.html

Talk live with:

Vergel has been HIV positive for 21 years and will share his first-hand experience.

This Live Chat is sponsored by:

Join our chat with Vergel about emerging, life-saving rescue therapy options for those who have tried most available HIV medicines and have not attained an undetectable viral load. On Wednesday, February 16, 2005, at 9 p.m. EST (Eastern Standard Time)/6 p.m. PST (Pacific Standard Time), will talk about Fuzeon (T-20, enfuvirtide), tipranavir (a new protease inhibitor in expanded access) and current research studies that people can join to access new drugs. has been HIV positive for 21 years and is one of the leading treatment advocates in the field of multi-drug resistance. He speaks internationally about such subjects as multi-drug resistant HIV, wasting, nutrition and side effects management. He has developed resistance to all currently approved medications.

Click here to submit a question in advance.

Submit your e-mail address below and we'll give you a heads-up both the week of the chat session and again a few hours before it is scheduled to start.

Privacy Policy

Ask a question in advance!You can submit questions in advance to help ensure that your concerns are covered. Click here to submit a question.

©2005 TheBody.com | Privacy Policy | Ask a Question

SPONSORED BY TRIMERIS/ROCHE

• MARK YOUR CALENDAR: HIV TREATMENT CHAT NEXT WEDNESDAY!Treatment Advocate Vergel Chats About Drug Resistance, Rescue TherapyAre you running out of HIV treatment options? Have you been told that your HIV is resistant to many HIV meds? Visit The Body on Wednesday, Feb. 16 at 9 p.m. Eastern Standard Time (6 p.m. Pacific) to talk about it! Widely known HIV treatment advocate Vergel will answer any questions you might have about drug resistance, third-line treatment, new antiretrovirals or keeping a positive outlook when your HIV treatment possibilities are shrinking. Visit our chat page now to presubmit your questions!Click here to learn more about our chat's host, the effusive, energetic Vergel.This chat is sponsored by Trimeris and Roche, the makers of Fuzeon (enfuvirtide, T-20).